HHS sues Gilead for refusing to reach a licensing deal over patents for HIV prevention pills

After more than a year of controversy, the federal government filed a lawsuit accusing Gilead Sciences (GILD) of infringing patents on a pair of HIV prevention pills and unfairly reaping hundreds of millions of dollars from research funded by taxpayers.